Clinical Study

Long Term Survival Analysis of Hepatectomy for Neuroendocrine Tumour Liver Metastases

Table 3

Summaries of the 12 patients with NELM.

PatientAgeSexTumour originNumber of tumoursType of liver resectionMitotic figuresKi-67 expression >5%Survival (months)Deceased/Alive

142FPancreasMultiple nodulesExtended left hepatectomyNANo25.11Deceased
252FUnknown1Right trisegmentectomyLowNo57.80Deceased
345FUnknown1Right trisegmentectomy HighNo4.04Deceased
458MPancreasMultiple nodulesWedge resectionLowNo52.84Deceased
537MUnknown1Left hepatectomy LowYes31.51Alive
650FPancreasMultiple nodulesLeft lateral sectionectomy and caudate lobectomyLowYes16.27Deceased
745MAdrenalMultiple nodulesLeft hepatectomyLowNo14.46Deceased
866MPancreas4Right hepatectomyNANo21.82Alive
967MUnknown1Wedge resectionLowYes51.07Alive
1071MPancreas3Right hepatectomyNANo13.64Deceased
1147MColon1Wedge resectionLowNo32.47Alive
1220FPancreas1Extended right hepatectomyNANo24.88Alive